Landomycin E (LE) is an angucycline antibiotic produced by Streptomyces globisporus. Previously, we have shown a broad anticancer activity of LE which is, in contrast to the structurally related and clinically used anthracycline doxorubicin (Dx), only mildly affected by multidrug resistance-mediated drug efflux. In the present study, cellular and molecular mechanisms underlying the anticancer activity of landomycin E towards Jurkat T-cell leukemia cells were dissected focusing on the involvement of radical oxygen species (ROS). LE-induced apoptosis distinctly differed in several aspects from the one induced by Dx. Rapid generation of both extracellular and cellderived hydrogen peroxide already at one hour drug exposure was observed in case of LE but not found before 24 h for Dx. In contrast, Dx but not LE induced production of superoxide radicals. Mitochondrial damage, as revealed by JC-1 staining, was weakly enhanced already at 3 h LE treatment and increased significantly with time. Accordingly, activation of the intrinsic apoptosis pathway initiator caspase-9 was not detectable before 12 h exposure. In contrast, cleavage of the down-stream caspase substrate PARP-1 was clearly induced already at the three hour time point. Out of all caspases tested, only activation of effector caspase-7 was induced at this early time points paralleling the LE-induced oxidative burst. Accordingly, this massive cleavage of caspase-7 at early time points was inhibitable by the radical scavenger N-acetylcysteine (NAC). Additionally, only simultaneous inhibition of multiple caspases reduced LE-induced apoptosis. Specific scavengers of both H 2 O 2 and OH
Introduction
The anthracycline family of polyketide antibiotics has been one of the most intensely studied classes of microbial natural products for development of antimicrobial and antitumor agents. Daunorubicin and doxorubicin (Dx) were the first anthracyclines approved as anticancer drugs in 1967 and 1974, respectively, and since then they have been toxic hydroxyl radicals in the presence of Fe 2+ ions (Fenton reaction) [2] . In addition, the emergence of multi-drug resistance in cancer cells upon long-term treatment poses serious limitations for the use of anthracyclines in clinical oncology [3] . Thus, the search for other anthracycline analogs which are less toxic and less affected by drug resistance mechanisms remains a crucial task of systemic cancer therapy research. Soil-dwelling gram-positive actinobacteria, especially members of the genus Streptomyces, became the main source of novel anthracycline analogs. The angucyclines are the largest group of polycyclic aromatic polyketides produced by Streptomyces with currently more than 120 described derivatives [4, 5] . The most characteristic feature of angucyclines is their uniquely shaped benz [a] anthracene tetracyclic framework with an angularly condensed ring [6] . This "curved" aglycon distinguishes angucyclines from other aromatic polyketides and is at least partially responsible for the wider range of bioactivities of angucyclines compared to, for instance, anthracyclines and tetracyclines [5] . Although the group is rich in chemical scaffolds and various biological activities, predominantly antitumor and antibacterial, none of these compounds has been developed to clinical use so far mostly due to toxicity or solubility issues [4, 5, 7] . Landomycins are the most auspicious group of angucyclines possessing strong antineoplastic potential. All natural landomycins identified to date share the same aglycon (landomycinone) and vary in their oligosaccharide chain, a linear glycosidic chain containing only di-and tri-deoxysugars (β-Dolivose and α-L-rhodinose) [8] . They show broad range of activity against many cancer cell lines, with the general tendency that compounds with longer saccharide chains show enhanced potency [9, 10] .
The best-investigated compound, landomycin A, containing a hexasaccharide side chain, has so far been shown to be the most potent congener. It has been extensively tested by the National Cancer Institute (USA) towards the 60 selected human cancer cell line panel and particularly prostate cancer models [11, 12] . In contrast to many clinically useful drugs of similar structure, like the anthracyclines and chromomycins, landomycins do not bind directly to DNA [6, 13, 14] . Landomycin E (LE) is a novel representative of landomycins synthesized by Streptomyces globisporus strain 1912 growing in a soy-bean culture medium [15, 16] . It contains three saccharide residues (α-L-rhodinose-(1→3)-β-D-olivose-(1→4)-β-D-olivose) conjugated to an angular tetracyclic quinone (Fig. 1) . Potent antitumor activity of LE was demonstrated against various tumor cell lines in vitro [17] and Guerin carcinoma in rats in vivo [18] . LE is widely unaffected by resistance to Dx, vincristine and colchicine in cancer cells based on overexpression of various types of ABC-transporters (ABCB1, ABCC1, ABCG2) [13, 14] . Pre-treatment with the ROS scavenger N-acetylcysteine (NAC) significantly lowered LE cytotoxicity towards KB-3-1 carcinoma cells [14] which suggests possible ROS involvement in LE-induced apoptosis in tumor cells. However, the exact molecular mechanisms underlying the antineoplastic effect of LE are still not fully elucidated.
Consequently, the main aim of the present study was to dissect in more detail the role of ROS in the anti-leukemic activity of LE as compared to Dx and to elucidate the involved cell death pathways.
Materials and methods

Materials
LE-overproducing Streptomyces globisporus 1912 strain was obtained in the laboratory of Prof. B. Matselyukh (D.K. Zabolotny Institute of Microbiology and Virology, National Academy of Sciences of Ukraine, Kyiv). LE (99.5% purity, according to HPLC data) was prepared in the laboratory of Prof. J. Rohr (University of Kentucky, USA) and dissolved in absolute ethanol to obtain a 4 mg/ml stock solution. Dx hydrochloride was obtained from Pfizer (New York, NY). Catalase from bovine liver (C9322), catalase-polyethylene glycol (C4963), superoxide dismutase from bovine erythrocytes (SOD; S7571), N-acetylcysteine (A7250), diphenyleneiodonium chloride (DPI; D2926), N,N′-dimethylthiourea (DMTU; D188700) and D-mannitol (M4125) were purchased from Sigma-Aldrich (St. Louis, MO). Caspase inhibitors Ac-DEVD-CHO (caspase-3/7 dual reversible inhibitor, ALX-260-030), Ac-IETD-CHO (caspase-8 reversible inhibitor, ALX-260-043), Ac-LEHD-CHO (caspase-9 reversible inhibitor, ALX-260-079) and z-VAD-fmk (ALX-260-020) were purchased from Enzo Life Sciences (Farmingdale, NY). Chemical formulas for LE and Dx are depicted in Fig. 1. 
Cell culture and treatments
Jurkat human T-leukemia cells were obtained from ATCC. Cells were cultured in RPMI medium, supplemented with 10% fetal calf serum (Sigma-Aldrich), 50 µg/ml streptomycin (Sigma-Aldrich), 50 units/ml penicillin (Sigma-Aldrich) in 5% CO 2 -containing humidified atmosphere at 37°C. For experiments cells were seeded into 24-well tissue culture plates (Greiner Bio-one, Germany). Short-term (24 h) cytotoxic effect of antitumor drugs was studied under the Evolution 300 Trino microscope (Delta Optical, Poland) after cell staining with trypan blue dye (0.1%).
Catalase (15 mg/ml, equivalent to 45 kU/ml) was dissolved in 50 mM potassium phosphate buffer, pH 7.0, while SOD (1000 U/ml) was dissolved in 0.1 M potassium phosphate, pH 7.5, catalase-polyethylene glycol was dissolved in sterile water (1 mg/ml, equivalent to 40 kU/ml). NAC, DMTU and D-mannitol were dissolved in 1x phosphate buffered saline (PBS). Antioxidants were added to cell culture 30 min before addition of anticancer drugs, and final concentration of catalase was 1000 U/ml, SOD 50 U/ml, D-mannitol 40 mM, and NAC 1 mM. Diphenyleneiodonium chloride was dissolved in DMSO to obtain a 10 mM stock solution, which was dissolved in PBS (final concentration 5 µM) and added to cell culture 30 min before addition of anticancer drugs. Caspase inhibitors were dissolved in DMSO to prepare 20 mM stock solutions and were added to cell culture (final concentration 50 µM) 1 h before addition of anticancer drugs.
For long-term (72 h) cytotoxicity assays, Jurkat cells were plated (5×10 3 ) in 100 µl per well in 96-well plates, and allowed to grow for 24 h. Drugs were added in another 100 µl culture medium and cells were exposed for 72 h. The proportion of viable cells was determined by EZ4U assay according to the manufacturer's recommendations (EZ4U, Biomedica, Vienna, Austria). Cytotoxicity was expressed as IC 50 values calculated from full dose-response curves (drug concentration including 50% reduction in cell survival comparing to the control cultured in parallel without drug). 
Flow cytometric assays
Jurkat T-leukemia cells were treated as indicated in the figures. For cell death analyses, cells were stained with Annexin-V-FITC (or Annexin-V-APC) and propidium iodide (PI) using an apoptosis detection kit (BD Biosciences, San Jose, CA), according to the manufacturer's instructions. In detail, 24 h after the addition of LE doses at LC 75 (6 µM) and LC 90 (8 µM) Jurkat cells were centrifuged at 2000 rpm, washed twice with 1x PBS, and incubated for 15 min in Annexin V-binding buffer (BD Biosciences, San Jose, CA) containing 1/50 vol of FITC-or APC-conjugated Annexin V solution and PI (50 µg/ml). Then samples were diluted 2 times in Annexin V-binding buffer (BD Biosciences, San Jose, CA) and immediately measured on FL1/FL2 (FITC/PI) or FL4/FL2 (APC/PI) channels of FACSCalibur flow cytometer (BD Biosciences, San Jose, CA) using Summit v3.1 software (Cytomation, Inc., Fort Collins, CO).
Breakdown of ΔΨm mitochondrial membrane potential was determined by FACS analysis using 5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraethylbenzimidazolylcarbocyanine iodide (JC-1). For this purpose, the Mitochondrial Membrane Potential Detection Kit (Stratagene, La Jolla, CA, USA) was used as described in the manufacturer's instruction. Briefly, 10 6 Jurkat cells were treated for 1, 3, 6, 12 and 24 h with the tested drugs. After PBS washing, cells were incubated for 10 min in freshly prepared JC-1 solution (10 mg/ml in culture medium) at 37°C. Spare dye was removed by PBS washing and cell-associated fluorescence was measured with FACS. Rhodamine 123 (Rh123) accumulation assays were performed as previously described [19] . Briefly, 5×10 
Western blotting
Western blot analysis was used to evaluate expression of proteins involved in cell cycle signaling pathways during treatment of Jurkat Tcells with LE at various time points (1, 3, 6, 9, 12, 24 h ). The cells were washed twice on ice with PBS before the addition of lysis buffer (20 mM Tris/HCl, pH 7.5, 150 mM NaCl, 0.5% Triton X-100, 1% Trasylol, 1 mM PMSF), 20 µl per 10 6 cells, vortexed and centrifuged. Protein concentration in supernatants was measured, as described [20] . 
Statistical analyses
Where not indicated otherwise, statistical comparisons were conducted using Student's t-test. Statistical significance was set at P≤0.05.
Results
NAC protects leukemia cells from LE-but not from Dx-induced cell death
Previously we have shown that the cytotoxic activity of LE can be significantly inhibited by pre-treatment of target cells with the ROS scavenger NAC [14] indicating involvement of ROS in LE-induced cancer cell death. However, the exact molecular mechanisms of these processes have not been completely elucidated yet. As ROS are short living molecules, we compared the impact of NAC on the anti-leukemic potential of LE and Dx at both early (24 h) and late (72 h) time points (Fig. 2 ). In the short exposure experiment, 1 mM NAC effectively inhibited the cytotoxic activities of LE over the entire tested concentration range restoring the viable cell population to 75-95% of the untreated control. In contrast, in case of Dx only an insignificant trend towards a protective effect of NAC was observed. At 72 h exposure, these differences became even more distinct with NAC completely eliminating the anticancer activity of LE opposed to a complete lack of impact in case of Dx-induced effects. Based on these data, sub-LC 50 (2 µM and 4 µM), LC 75 (6 µM) and LC 90 (8 µM) doses of LE were used in our further studies. Dx doses, used for comparison, were 0.5 µM (LC 75 ) and 1 µM (LC 90 ).
LE in contrast to Dx leads to early hydrogen peroxide but not superoxide anion production
To further investigate the role of ROS in LE-induced cell death, timedependent ROS production was measured in LE-and Dx-treated Jurkat cells by flow cytometry. The ROS indicator fluorescent dyes DCFDA and DHE were used to distinguish between H 2 O 2 and O 2
•− , respectively. LE led to a rapid increase of hydrogen peroxide levels in a concentrationdependent manner (2.5-and 5-fold increase at 2 µM and 4 µM, respectively) peaking already at 1 h exposure (Fig. 3 ). H 2 O 2 stimulation by LE followed a biphasic pattern with reduced but still significant upregulation at 3 h and 6 h followed by a second peak at 12 h and again mild attenuation at 24 h. NAC distinctly blocked H 2 O 2 production in response to LE over the whole incubation time. Dx treatment, in contrast to LE, did not result in considerable upregulation of H 2 O 2 levels up to 12 h exposure time. However, at longer exposure times (12 h, 24 h), H 2 O 2 production was moderately (up to 2.5-fold) increased also by Dx. NAC did not inhibit hydrogen peroxide production by Dx. In contrast to H 2 O 2 , LE rather reduced (up to 3-fold) than increased superoxide radicals production at early time points (1-3 h), while O 2
•− levels were slightly but insignificantly increased as compared to the control at longer exposure (12-24 h) (Supplemental Fig. 1 ). Dx strongly induced superoxide radical production with a peak activity at 24 h exposure. NAC had no inhibitory impact on this process.
LE causes earlier mitochondrial damage and membrane depolarization as compared to Dx
Mitochondria are known to be one of the main sources of ROS in the cells. Thus, the impact of LE and Dx on the status of mitochondria was comparatively investigated. First, rhodamine-123 accumulation data suggested that LE led to dose-dependent mitochondrial damage already after 1 h exposure (Supplemental Fig. 2 ). LE-mediated reduction of Rh-123 fluorescence was dose-dependent and peaked at 6 h followed by partial recovery until 24 h exposure time. In contrast to LE, Dx, had no impact on mitochondrial integrity at early time points (from 1 h to 12 h), while after 24 h massive mitochondrial damage occurred. In line with the DCFDA and viability data, LE-induced mitochondrial damage was partially recovered by NAC, although this effect was much weaker as compared to the impact in cell viability assays (compare Fig. 2 ). In contrast, NAC did not protect from Dx-induced mitochondrial damage.
As a second parameter of mitochondrial integrity, the mitochondrial membrane potential was followed by JC-1 staining (Fig. 4) . Weak signs of mitochondrial membrane depolarization by LE were observed only at 3 h, reaching a peak at 12 h exposure (21% of depolarized mitochondria for LE 2 µM and 42% for LE 4 µM) followed by partial recovery after 24 h. Dx-induced mitochondrial membrane depolarization occurred later and was relatively weak up to 12 h followed by a massive effect at 24 h (41% for 0.5 µM and 67% for 1 µM Dx). DCFDA is considered to be the indicator of diverse ROS (e.g. hydrogen peroxide, hydroxyl radicals, peroxynitrite radicals and others) [21] . Consequently, the increase in DCFDA fluorescence by LE does not allow identifying the exact type of ROS detected. Conversely, NAC -besides being a precursor for cellular glutathione -belongs to thiol-type ROS scavengers and is known to block also other types of ROS in addition to the ones derived from H 2 O 2 [22] . Considering the quinone structure of LE, NAC might even reduce semiquinone radicals to their corresponding hydroquinones [23] . Thus, to allow a more Fig. 3 . LE but not Dx induces a massive and rapid hydrogen peroxide burst in Jurkat cells, which is inhibitable by NAC. DCFDA fluorescence of Jurkat cells indicative for H 2 O 2 generation was determined by flow cytometry at the indicated time points after addition of LE or Dx to Jurkat cell cultures without and with addition of 1 mM NAC. Data are given relative to the untreated control samples and represent the mean ± SD of three independent experiments. *p < 0.05 relative to control, ** p < 0.01 relative to control, *** p < 0.0001, unpaired t-test. Significance levels indicated directly above bars refer to the comparison with the respective vehicle-treated controls.
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Fig. 4 . LE leads to rapid but moderate depolarization of mitochondria, which is partially inhibitable by NAC. Cells were pre-treated for 30 min with 1 mM NAC, followed by addition of either vehicle (control, C) or sub-LC 50 doses of LE and Dx for the indicated exposure times. Cells were stained with JC-1 for analysis by flow cytometry. Data depict the proportion of cells with depolarized mitochondria (exerting green JC-1 fluorescence) relative to the vehicle control. Bars represent the mean ± SD of three independent experiments. *p < 0.05, ** p < 0.01, *** p < 0.0001, unpaired t-test. Significance levels indicated directly above bars refer to the comparison with the respective vehicle-treated controls. • p < 0.05 relative to LE 8 µM.
•• p < 0.01 relative to LE 8 µM.
• precise identification of the ROS induced by short-term LE exposure, specific scavengers of hydrogen peroxide (catalase), hydroxyl radicals (mannitol, DMTU) and superoxide radicals (SOD) were used (Table 1 and Fig. 5 ). To avoid interference with the growth-supporting effects of antioxidants [24] , higher (namely, LC 75 and LC 90 ) doses of LE were used in this experiment. As expected, these massively cytotoxic concentrations led to higher DCFDA fluorescence (6-fold and 7.4-fold increase, respectively) compared to sub-LC 50 doses (compare Fig. 3) . Table 1 . Data are given relative to the vehicle-treated control and represent the mean ± SD of three independent experiments. *p < 0.05, ** p < 0.01, *** p < 0.0001, unpaired t-test. Significance levels indicated directly above bars refer to the comparison with the respective vehicle-treated controls.
Co-incubation with catalase significantly decreased LE-induced DCFDA fluorescence, thus confirming a crucial role of hydrogen peroxide in LEinduced oxidative burst. Mannitol and DMTU (OH • scavengers) exerted weaker effects, thus indicating a more secondary role of hydroxyl radicals in this process. Finally, SOD had a very weak effect on DCFDA fluorescence at all studied time points indicating no contribution of superoxide radicals in LE-induced ROS burst. Surprisingly, combination of catalase and mannitol had almost no synergistic effect, while simultaneous addition of catalase, mannitol and SOD (CMS) exerted a massive ROS-scavenging effect even exceeding the one of NAC at least at 1 h exposure (Table 1 and Fig. 5 ).
As a next step, the impact of ROS scavengers on the apoptosisinducing effects of LE was investigated using annexin V/PI double staining (LE at 6 µM in Fig. 6 ; as well as controls and LE at 8 µM in Supplemental Fig. 3) . Surprisingly, despite strong hydrogen peroxide scavenging activity, catalase exerted only a minor protective effect. The same holds true for mannitol, while the impact of SOD was negligible. In contrast, NAC massively reduced apoptosis induction. Combination of catalase, mannitol and SOD exerted a synergistic protective effect, but was still distinctly lower compared to effect of NAC alone. Together this indicates that ROS play a significant but not dominant role in LEinduced apoptosis and NAC is able to protect cells by additional, probably ROS-independent effects.
Localization of LE-mediated H 2 O 2 generation
Consequently, as a next step we aimed to determine the localization of LE-mediated ROS production. The enzyme catalase is too big (60 kD) to enter the cell by diffusion thus allowing mainly extracellular scavenging of radicals and hydrogen peroxide. Hence, we compared the impact of unmodified catalase with that of a cell-permeable catalase-polyethylene glycol conjugate in the DCFDA assay (Fig. 7A) . Interestingly, the inhibition of ROS-production by intracellular PEGylated catalase was less potent as compared to extracellular catalase and did not reach statistical significance. Thus, the main source of the LE-induced hydrogen peroxide boost seems to be located either extracellularly or in close proximity to the cell membrane. To estimate cell-free versus cell-dependent H 2 O 2 production, we determined hydrogen peroxide levels induced by LE in comparison to Dx and the well-defined H 2 O 2 -inducing quinone menadione [25] in absence and presence of cells (Fig. 7B, upper panel) . As the DCFDA assay is not specific for H 2 O 2 and considering that all these fluorescence ROS detection methods are relatively vulnerable to produce artefacts [26] , we employed the ROS-Glo H 2 O 2 assay kit. Both LE and menadione upregulated H 2 O 2 production already in cell-free culture medium, but the induction was significantly higher in the presence of cells especially in the case of LE. In contrast, Dx did not induce detectable H 2 O 2 levels under both conditions. Hence, we concluded that LE-mediated cellular H 2 O 2 upregulation is integrating cell-free quinone-mediated redox processes and -to a higher degree -cell-bound mechanisms.
There are several cellular sources of hydrogen peroxide, but mitochondrial NADPH dehydrogenases and membrane-bound NADH oxidases are considered central ones [27, 28] . Based on the catalase data mentioned above, mitochondria are for sure not a major source of LEinduced hydrogen peroxide. To address the role of membrane-bound NADH oxidases, we investigated the impact of DPI -a broad spectrum inhibitor of NADPH oxidases [29] -with LE (Fig. 7C) . Unexpectedly, co-incubation with DPI led to distinctly increased rather than decreased ROS production in combination with LE. Hence also plasma membranebound NAPDH oxidases are unlikely as major players in this process.
Characteristics of NAC-mediated protection against LE-induced hydrogen peroxide production and cytotoxicity
To dissect factors explaining the massive NAC-mediated protection from LE-mediated cytotoxicity, NAC was added to LE in the ROS-Glo H 2 O 2 assay kit (Fig. 7B, lower panel) . Interestingly, NAC massively blocked hydrogen peroxide generation in the presence of cells while cell-free H 2 O 2 upregulation was widely insensitive. Next we addressed the question whether intracellular glutathione enhancement or already extracellular interactions might underlie NAC-based protection against LE-mediated apoptosis induction. Therefore, continuous presence of NAC during LE exposure was compared with NAC pre-exposure but washout before LE administration (Fig. 7D) . Intracellular glutathione upregulation was sufficient to reduce LE-mediated apoptosis by about 50%. However, continuous presence of NAC almost completely eliminated the cytotoxic activity of LE. These data suggest that extracellular NAC and intracellular glutathione enhancement cooperate in NACmediated protection against LE.
Last we addressed the question, whether NAC might block cellular LE uptake. For that we utilized the low intensity fluorescence produced by intracellular LE which is detectable in the FITC/FL1 FACS channel (Fig. 7E) . Indeed, presence of NAC distinctly reduced but not completely blocked intracellular LE fluorescence while Dx-mediated fluorescence was completely unaffected by NAC also in the appropriated PE/ FL2 channel (Supplemental Fig. 4 ). This suggests that NAC not only quenches cell-associated ROS production but also cellular LE uptake. The underlying mechanism is currently addressed by ongoing experiments.
LE induces a unique death signaling pathway with activation of effector caspase-7 preceding mitochondrial damage
ROS-producing anticancer drugs frequently induce apoptosis via the intrinsic, mitochondrial pathway. However considering the relatively weak protection of ROS scavengers and comparably minor mitochondrial depolarization by LE, we hypothesized on other cell death induction mechanisms inhibitable by NAC. Thus, the LE-mediated activation of several initiator and effector apoptotic proteins involved in various types of apoptosis (ER-induced, mitochondria-mediated) was analyzed (Fig. 8) . Unexpectedly, activation of initiator caspase-9, involved in mitochondria-mediated apoptosis, was not detectable before 9 h of LE treatment and this process was not inhibited but rather enhanced by NAC. Also activation of several other initiator caspases involved in receptor-mediated (caspases-8, -10) or ERmediated (caspase-2) apoptosis was either not observable or did not occur prior to 12-24 h LE exposure. Activation of the main effector caspase-3, involved in crucial steps of cell death, was detectable from 12 h LE treatment onwards. In contrast to these initiator caspases, NAC- Supplemental Fig. 4 ). Data given represent mean and SD of two to three independent experiments in duplicate. *p < 0.05, **p < 0.01, *** p < 0.001 by unpaired t-test. Stars directly above the bars indicate differences to the respective vehicle controls.
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inhibitable activation of effector caspase-7 was readily observable already at 3 h LE treatment accompanied by distinct PARP-1 cleavage (Fig. 8) . Interestingly, NAC inhibited caspase-7 activation only at 3 h and 6 h, while later on this process becomes NAC-insensitive correlating well with the impact of NAC on LE-induced ROS production (compare Fig. 3 ). These data indicate that rapid hydrogen peroxide production by LE treatment might be involved in activation of caspase-7 while activation of caspase-9 might be a secondary event. In contrast, Dxinduced apoptosis followed the classical sequence by induction of caspase-9 and subsequent activation of effector caspases-3/7 (Supplemental Fig. 5 ).
To further dissect the role of caspases in LE-induced Jurkat cell death, the impact of specific inhibitors of caspase-3/7 (Ac-DEVD-CHO), caspase-8 (Ac-IETD-CHO), caspase-9 (Ac-LEHD-CHO) and the pancaspase inhibitor z-VAD-fmk were compared. Only the dual caspase-3/7 inhibitor led to a minor decrease in the number of AnV (+) cells, while inhibition of either caspase-8 or caspase-9 alone did not reduce the cytotoxic activity of LE (Fig. 9) . However, simultaneous addition of Ac-DEVD-CHO, Ac-IETD-CHO and Ac-LEHD-CHO exerted synergistic activities distinctly decreasing the number of AnV (+) cells. Preincubation of Jurkat T-cells with pan-caspase inhibitor z-VAD-fmk massively reduced the number of apoptotic cells, clearly indicating on crucial role of obviously several caspases in execution of LE-induced cell death.
In addition, we tested the combination of the caspase inhibitors and ROS scavengers (catalase, SOD, mannitol) on the apoptotic potential of LE. Unexpectedly, the combination of Ac-DEVD-CHO, Ac-IETD-CHO and Ac-LEHD-CHO with the scavengers demonstrated additive to synergistic protective effects against LE (Supplemental Fig. 6 ). In contrast, addition of the scavengers to the pan-caspase inhibitor resulted in only marginal increase of the protective effect. Thus, simultaneous inhibition of ROS production and caspases-3,8,9 strongly reduced the anticancer activity of LE. These data suggest a complex interplay of ROS generation and caspase activation in LE-induced apoptosis.
Discussion
ROS in the context of cell biology comprise a group of small molecules with significant oxidative activity including highly reactive free oxygen radicals, such as superoxide anion [O 2
•− ] and the hydroxyl [30] . The impacts of ROS on cell biology are ambivalent. On the one hand, they have been implicated in the regulation of essential cellular functions, including cell cycle, proliferation and apoptosis based on their function as second messengers in signal transduction. On the other hand, ROS overproduction can lead to oxidative damage of key cellular components and induction of cell death. This implicates that in healthy organs the physiological levels of Fig. 8 . Impact of LE treatment on caspases, caspase substrates and other apoptosisregulating proteins in human Jurkat T-leukemia cells. Total proteins extracts of 2 µM LEtreated Jurkat cells without and with 1 mM NAC were isolated at the indicated timepoints and analyzed by Western-blot. ß-actin was used as loading control. Insets give densitometric quantification relatively to the β-actin loading control. Fig. 9 . Impact of caspase inhibitors on LE-induced apoptosis. Jurkat cells were pretreated for 1 h with specific caspase inhibitors (Ac-DEVD-CHO, reversible casapse-3/7 inhibitor; Ac-IETD-CHO, reversible caspase-8 inhibitor; Ac-LEHD-CHO, reversible casapse-9 inhibitor) and the pan-caspase inhibitor z-VAD-fmk (all 50 µM). Then LE at the LC 75 dose (6 µM) was added for 24 h. Cells were stained with FITC-annexin V (AnV) and propidium iodide (PI) for further analysis of apoptosis induction by flow cytometry. *p < 0.05 relative to control, ** p < 0.01 relative to control, unpaired t-test.
ROS have to be strictly controlled. Malignant tissues, however, are characterized by deregulated ROS homeostasis and, consequently, cancer cell survival depends on massive upregulation of antioxidant systems like glutathione and ROS-metabolizing enzymes. This protective barrier allows cancer cell survival despite massive redox deregulation and even permits utilization of specific ROS-mediated signals to support malignant progression [31] . Nevertheless, based on these high ROS levels cancer cells are hypersensitive for further redox deregulation by several anticancer compounds. Consequently, the pharmacological generation of enhanced oxidative stress in cancer tissues, also termed "oxidation therapy", is an active era of targeted therapy development [32] . Additionally, several anticancer drugs of both synthetic and natural origin induce apoptosis in tumor cells by mechanisms involving ROS [33] . However, while the contribution of ROS to the activity especially of some quinone-like drugs and anthracyclines like menadione and Dx were analyzed in detail, in case of other even clinically used cancer compounds the exact factors of ROS generation and its consequences have not always been worked out in detail [32, 34, 35] . However, the dissection of ROS production in frame of systemic cancer therapy is critical as they might not only be mode-ofaction for anticancer drugs but also a main cause of even dose-limiting adverse effects. In that respect, anthracyclines are particularly problematic. While the role of ROS in their in vitro and in vivo anticancer effects is questionable [36, 37] , the contribution of superoxide in cardiotoxicity, as major side effect, is beyond doubt [38] . In accordance, we were unable to protect KB-3-1 cervix cancer cells against Dx by application of the broad ROS scavenger NAC, while the anticancer activity of LE was completely blocked [14] .
Based on these observations and considering the quinone moiety in the LE structure, we hypothesized that LE in contrast to Dx might represent a novel strategy for anticancer "oxidation therapy". Using Jurkat leukemic cells, we demonstrate in the present study that the apoptosis-inducing mechanism of LE is indeed involving a complex temporal sequence of ROS generation and caspase activation. This ROSinvolving cell death cascade is completely different from the cytotoxic effects induced by the related and clinically used anthracycline drug Dx. In the leukemic Jurkat cell model, the cytotoxic effect of Dx was insensitive to NAC application, while LE activity was massively inhibited. Unexpectedly, hydrogen peroxide production by LE exposure was rapidly and massively induced within 1 h followed by a steep decline and a second lower peak at 12-24 h. However, only a tendency towards increased superoxide anion levels was detectable at 12 h. For Dx, in contrast, generation of superoxide radicals was detectable culminating at 24 h exposure together with mitochondrial damage. Accordingly, the late upregulation of DCFDA staining by Dx supports secondary generation of H 2 O 2 from superoxide radicals via SOD, while an additional generation of hydroxyl radicals in a Fenton reaction is feasible [39] . Interestingly, the maximum level of mitochondrial depolarization by LE treatment was observed in parallel to the comparably late superoxide anions production, suggesting that these two events might be mitochondria-derived. Accordingly, the second peak of H 2 O 2 generation during LE exposure might be explainable by conversion of mitochondria-derived superoxide anions by SOD to hydrogen peroxide as part of cellular ROS detoxification processes [40] . Together these data would suggest that the classical mitochondria-mediated ROS-derived cell death pathway might not initiate but only support LE-induced apoptosis at later time points. This is also confirmed by the activation of initiator caspase-9 and caspase-3 in Western blot analysis and by the necessity for combining caspase 3/7 inhibitor with at least a caspase 9 and caspase 8 inhibitor to significantly reduce LE-mediated apoptosis. In case of Dx, neither mitochondrial depolarization nor apoptosis induction was sensitive to NAC. This suggests that superoxide radicals do not play a major role in the anticancer activity of Dx.
The early oxidative burst by LE was accompanied by activation of effector caspase-7 at 3 h treatment. Co-incubation with NAC was able to significantly and at least partly attenuate early ROS and caspase-7 activation and massively inhibited LE-mediated cell death induction. Together, these data would suggest a central role of H 2 O 2 in the modeof-action of LE. However, inhibition of hydrogen peroxide production by catalase and/or by mannitol and DMTU (scavengers of hydroxyl radicals) only moderately inhibited apoptosis induction by LE, while NAC (as thiol-type ROS scavenger) demonstrated massive protective effects. Joint combination of catalase, mannitol and SOD demonstrated an additive protective effect which, however, was surprisingly still weaker as compared to NAC. On the one hand this indicates that during different stages of LE-derived apoptosis all three types of ROS (H 2 O 2 , OH
• , O 2 •− ) seem to participate. On the other hand, their production does not seem to be the sole mechanism of cell death induction by LE. The high efficiency of NAC in blocking LE-induced ROS production and apoptosis might be explained either by scavenging of other ROS species not hit by catalase, mannitol or SOD or, more likely, by ROSindependent functions of this thiol-containing antioxidant. Indeed we found that NAC did not only potently scavenge cell-dependent H 2 O 2 production by LE but also reduced LE-mediated intracellular fluorescence. This suggests that NAC probably might form covalent adducts with LE hence reducing cellular uptake. These possibilities are also supported by the fact that NAC pre-incubation to upregulate intracellular glutathione levels [41] reduced LE-induced apoptosis by about 50% while continuous presence of NAC almost completely abrogated the cytotoxic effects of LE. The interplay of these extra-and intracellular protection mechanisms is currently addressed in ongoing investigations. Additionally, we aimed to address the questions where LE-mediated ROS generation takes place and whether this is an extracellular or cellbound process. In our hands, LE -like the well-known quinone menadione -led to enhanced levels of H 2 O 2 already in cell-free culture medium. In that respect it needs to be taken into account that the cell culture media might contain free metal ions like copper and iron which are powerfully pro-oxidants and might lack antioxidants [42] . However, hydrogen peroxide levels were further distinctly enhanced in the presence of cells especially in case of LE. This strongly suggests that the hydrogen peroxide induced by LE is at least in part derived form a cell-bound redox cycling process of LE. Additionally, hydrogen peroxide is a relatively stable molecule, which can be easily transferred through various cellular membranes by aquaporins [43] , in contrast to superoxide anions, which cannot exit the organelles where they have been produced due to their negative charge [40] . The main physiological sources in mammalian cells are 1) mitochondrial electron transport chain (ETC)-derived electrons reacting with molecular oxygen to produce ROS or 2) cytosolic or membranous enzymes including besides the NADPH oxidases (NOX), xanthine oxidase and NADH: ubiquinone oxidoreductase (NQO1 and NQO2) also metabolic enzymes like cytochrome P450, lipoxygenase, and cyclooxygenase [44, 45] . Surprisingly, the efficiency of PEGylated (intracellular) catalase was significantly weaker compared to extracellular catalase to inhibit LE-induced hydrogen peroxide production. This clearly indicates that the early oxidative burst by LE is not derived from the mitochondrial respiration and occurs obviously at or close to the plasma membrane. The major enzymes located there, which could be responsible for H 2 O 2 generation, are membrane-bound NADPH oxidases [28] . However, pre-treatment of Jurkat T-cells with the broad flavoenzymes inhibitor DPI even enhanced H 2 O 2 levels in response to LE. This makes one electron reduction by intracellular flavoenzymes like NADPH oxidase, nitric oxide synthase, xanthine oxidase, and cytochrome P450 reductase unlikely [25, 46] . However, there are also several cytosolic proteins involved in the reduction of quinone-containing drugs -namely NQO1 and NQO2 [47, 48] . NQO1 has been shown to be the main target of β-lapachone -a novel anticancer ortho-quinone drug, which realizes its cytotoxic activity via ROS production [49] -while NQO2 was found to be associated with menadione-mediated hydrogen peroxide production possessing the same para-quinone core as LE [50] . Interestingly, also in that cases exogenous catalase was shown to decrease both ROS production and toxic effects of β-lapachone and menadione [51, 52] , indicating infact that H 2 O 2 production by NQO1 and NQO2 takes place in close proximity to the plasma membrane. This might also be an attractive explanation for lack of superoxide detection during LEmediated H 2 O 2 generation by what is known as comproportionation reaction [25, 46] . In that case, two electron reduction of LE via NQO1 would generate LEH2 which would be oxidized extracellularly by LE itself to form semiquinone radicals LE
•-which eventually might lead to H 2 O 2 generation. In agreement with our results, since this is not a superoxide-driven mechanism, SOD can no longer prevent H 2 O 2 generation.
However it needs to be take into account that DPI also inhibits two electron reduction by NQO1 and hence also blocks the formation of the respective hydroquinone [25, 46] . So how could the enigmatic upregulation of H 2 O 2 induction by LE in combination with DPI be explained? Besides blocking flavoenzymes and NQO1, DPI also has been demonstrated to induce a rapid and distinct efflux of reduced glutathione from the cells [53] . Glutathione, however, is the central protective mechanism against quinone toxicity, and many quinones not only directly interact with GSH but also induce expression of glutamate-cysteine ligase (GCL) as rate limiting step of glutathione production [25] . Together with the above-mentioned observations regarding the protection by NAC/glutathione, these data suggest that the reduced levels of intracellular GSH following DPI treatment, probably in combination with direct GSH targeting by LE, might explain the enhanced H 2 O 2 generation from cellular metabolism despite inhibition of flavoenzymes. H 2 O 2 overproduction as a consequence of an altered GSH/ GSSG ratio has recently also been suggested to be involved in cell death induction by 2-methoxy-6-acetyl-7-methyljuglone, another natural naphthoquinone [54] .
However, not only concerning the involvement of ROS but also with regard to the involved cell death machinery, LE-induced cytotoxicity seems to follow unconventional patterns. Surprisingly, we found that activation of the effector caspase-7 by LE preceded activation of other initiator caspases. This effect might be caused by direct oxidative modification of this enzyme by hydrogen peroxide, which is known to oxidize methionine residues and thiol groups of cysteines, e.g. for caspase-9 in Cys403 site [55] . This might result in a change in the redox status of the proteins and either can activate or inactivate the respective activity depending on H 2 O 2 concentration [56] . Our data indicate that LE-produced hydrogen peroxide is generated in close proximity to the plasma membrane. Taking into consideration that caspase-7 is associated predominantly with microsomal fraction and membranes [57] , one can assume that caspase-7 can be directly activated by LE-induced hydrogen peroxide. It has been already demonstrated, that low concentrations of hydrogen peroxide (50 µM, 50 fmoles per cell) are rapidly consumed by Jurkat T-cells already within 30 min in a situation resembling our incubation conditions. However, these doses of H 2 O 2 were enough to activate effector but not activator caspases (measured by DEVD-AMC cleavage) with 3 h delay, while higher doses of H 2 O 2 (> 200 µM) block caspase activation shifting apoptotic towards necrotic cell death [27] . Hence, LE seems to exert similar activity as low doses of H 2 O 2 , in particular, activation of caspase-7 immediately after drug exposure. LE indeed induces caspase-dependent apoptosis, as pancaspase inhibitor z-VAD-fmk almost completely blocked LE-induced cell death. However, caspases-3,8,9 seem to play minor roles here, as use of specific caspase-3/7 inhibitor Ac-DEVD-CHO led to a weak decrease in number of AnV (+) cells, while the caspase-8 inhibitor Ac-IETD-CHO, surprisingly, even tended to enhance the cytotoxic activity of LE. Nevertheless, combined application of Ac-DEVD-CHO, Ac-IETD-CHO and Ac-LEHD-CHO led to prominent apoptosis inhibition, thus indicating that these caspases obviously cooperate during LE-induced apoptosis. Moreover, pre-treatment of Jurkat T-cells with ROS scavengers and caspase-3,8,9 inhibitors also exerted cumulative effects. Thus, both ROS and caspases-3,8,9 exert significant and indispensable impacts on LE-induced apoptosis. However, this combination is still less effective compared to with the pan-caspase inhibitor z-VAD-fmk indicating on important role of other caspases (e.g., caspase-7) in LEinduced apoptosis. Interestingly, also ROS-dependent cell death induction by menadione was following a unique pattern by involving multiple redundant cell death pathways all depending on cleavage of the caspase substrate PARP-1 [58] .
Several caveats need to be considered concerning the in vivo relevance of our in vitro investigations based on massive differences between cell culture conditions and the physiological situation in tissues and organs (reviewed in [42] ). First, in vitro cell culture is performed under non-physiologically high oxygen concentrations (95% air, 5% CO 2 ) facilitating ROS production. Second, culture media may contain less antioxidants as compared to body fluids (e.g. tocopherols, ascorbate, vitamin E). Third, culture media lack selenium and thus some antioxidant mechanisms like thioredoxin reductase and glutathione peroxidase might be hampered. Forth, several metals in culture media like copper and iron might act as powerfully pro-oxidant. However, anticancer activity of LE has been already demonstrated in vivo ( [18] and unpublished data). Whether LE-dependent ROS generation identified in cultured cells in this study also contribute to this in vivo activity will be validated in forthcoming studies.
Collectively, our data suggest that LE exerts a unique mode of cell death induction involving ROS-dependent and -independent mechanisms based on its specific quinone-containing structure. LE-induced apoptosis involves, besides other radicals, early H 2 O 2 generation close to the cancer cell membrane leading to rapid caspase-7 activation. This effect cooperates with later depolarization of mitochondria and caspase-9/3 activation. The multi-targeted cell death pathway may explain the minor impact of drug resistance mechanisms on LE activity [13, 14] . Additionally, the lack of superoxide production anticipates absence or at least reduction of cardiotoxicity as compared to anthracyclines. Whether these features can be exploited to develop LE for use in systemic cancer therapy needs to be addressed in further studies.
